Predicting conversion from mild cognitive impairment to Alzheimer’s disease with multimodal latent factors

References

• Alzheimer’s Association. (2021). Alzheimer’s disease facts and figures. Alzheimer’s & Dementia, 17(3), 327–406. https://doi.org/10.1002/alz.12328
   PubMed Web of Science ®Google Scholar
• Barnes, D. E., Cenzer, I. S., Yaffe, K., Ritchie, C. S., & Lee, S. J. (2014). A point-based tool to predict conversion from mild cognitive impairment to probable Alzheimer’s disease. Alzheimer’s & Dementia, 10(6), 646–655. https://doi.org/10.1016/j.jalz.2013.12.014
   PubMed Web of Science ®Google Scholar
• Benjamini, Y., & Hochberg, Y. (1995). Controlling the false discovery rate: A practical and powerful approach to multiple testing. Journal of the Royal Statistical Society. Series B (Methodological), 57(1), 289–300. https://doi.org/10.1111/j.2517-6161.1995.tb02031.x
   Web of Science ®Google Scholar
• Blennow, K. (2004). Cerebrospinal fluid protein biomarkers for Alzheimer’s disease. NeuroRX, 1(2), 213–225. https://doi.org/10.1602/neurorx.1.2.213
   PubMedGoogle Scholar
• Boggs, L. N., Fuson, K. S., Baez, M., Churgay, L., McClure, D., Becker, G., & May, P. C. (1996). Clusterin (Apo J) protects against in vitro amyloid-β(1–40) neurotoxicity. Journal of Neurochemistry, 67(3), 1324–1327. https://doi.org/10.1046/j.1471-4159.1996.67031324.x
   PubMed Web of Science ®Google Scholar
• Bondi, M. W., Edmonds, E. C., Jak, A. J., Clark, L. R., Delano-Wood, L., McDonald, C. R., Nation, D. A., Libon, D. J., Au, R., Galasko, D., & Salmon, D. P., for the Alzheimer’s Disease Neuroimaging Initiative. (2014). Neuropsychological criteria for mild cognitive impairment improves diagnostic precision, biomarker associations, and progression rates, Journal of Alzheimer’s Disease, 42(1), 275–289. https://doi.org/10.3233/JAD-140276.
   PubMed Web of Science ®Google Scholar
• Browne, M., & Cudek, R. (1993). Alternative ways of assessing model fit. In K. Bollen & J. Long (Eds.), Testing structural equation models (pp. 136–162). Sage.
   Google Scholar
• Calsolaro, V., & Edison, P. (2016). Neuroinflammation in Alzheimer’s disease: Current evidence and future directions. Alzheimer’s & Dementia, 12(6), 719–732. https://doi.org/10.1016/j.jalz.2016.02.010
   PubMed Web of Science ®Google Scholar
• Cattell, R. B., & Vogelmann, S. (1977). A comprehensive trial of the scree and KG criteria for determining the number of factors. Multivariate Behavioral Research, 12(3), 289–325. https://doi.org/10.1207/s15327906mbr1203_2
   PubMed Web of Science ®Google Scholar
• Chang, M., & Brainerd, C. J. (2021). Factor analyses of the ADNI neuropsychological battery: An examination of diagnostic and longitudinal invariance. Neuropsychology, 35(4), 434–450. https://doi.org/10.1037/neu0000736
   PubMed Web of Science ®Google Scholar
• Chapman, R. M., Mapstone, M., McCrary, J. W., Gardner, M. N., Porsteinsson, A., Sandoval, T. C., Guillily, M. D., DeGrush, E., & Reilly, L. A. (2011). Predicting conversion from mild cognitive impairment to Alzheimer’s disease using neuropsychological tests and multivariate methods. Journal of Clinical and Experimental Neuropsychology, 33(2), 187–199. https://doi.org/10.1080/13803395.2010.499356
   PubMed Web of Science ®Google Scholar
• Chapman, R. M., Mapstone, M., Porsteinsson, A. P., Gardner, M. N., McCrary, J. W., DeGrush, E., Reilly, L. A., Sandoval, T. C., & Guillily, M. D. (2010). Diagnosis of Alzheimer’s disease using neuropsychological testing improved by multivariate analyses. Journal of Clinical and Experimental Neuropsychology, 32(8), 793–808. https://doi.org/10.1080/13803390903540315
   PubMed Web of Science ®Google Scholar
• Chen, T., Zeng, D., & Wang, Y. (2015). Multiple kernel learning with random effects for predicting longitudinal outcomes and data integration. Biometrics, 71(4), 918–928. https://doi.org/10.1111/biom.12343
   PubMed Web of Science ®Google Scholar
• Cheng, B., Liu, M., Zhang, D., Munsell, B. C., & Shen, D. (2015). Domain transfer learning for MCI conversion prediction. IEEE Transactions on Biomedical Engineering, 62(7), 1805–1817. https://doi.org/10.1109/TBME.2015.2404809
   PubMed Web of Science ®Google Scholar
• Cohen, J. (1957). A factor-analytically based rationale for the wechsler adult intelligence scale. Journal of Consulting Psychology, 21(6), 451–457. https://doi.org/10.1037/h0044203
   PubMedGoogle Scholar
• Costello, A. B., & Osborne, J. W. (2005). Best practices in exploratory factor analysis: Four recommendations for getting the most from your analysis. Practical Assessment, Research, and Evaluation, 10(7), 1–9. https://doi.org/10.7275/jyj1-4868
   Google Scholar
• Crane, P. K., Carle, A., Gibbons, L. E., Insel, P., Mackin, R. S., Gross, A., Jones, R. N., Mukherjee, S., Curtis, S. M., Harvey, D., Weiner, M., & Mungas, D. (2012). Development and assessment of a composite score for memory in the Alzheimer’s Disease Neuroimaging Initiative (ADNI). Brain Imaging and Behavior, 6(4), 502–516. https://doi.org/10.1007/s11682-012-9186-z
   PubMed Web of Science ®Google Scholar
• Cui, Y., Liu, B., Luo, S., Zhen, X., Fan, M., Liu, T., Zhu, W., Park, M., Jiang, T., & Jin, J. S., & the Alzheimer’s Disease Neuroimaging Initiative. (2011). Identification of conversion from mild cognitive impairment to Alzheimer’s disease using multivariate predictors. PLOS ONE, 6 (7), e21896. https://doi.org/10.1371/journal.pone.0021896
   PubMed Web of Science ®Google Scholar
• Cuingnet, R., Gerardin, E., Tessieras, J., Auzias, G., Lehéricy, S., Habert, M.-O., Chupin, M., Benali, H., & Colliot, O. (2011). Automatic classification of patients with Alzheimer’s disease from structural MRI: A comparison of ten methods using the ADNI database. NeuroImage, 56(2), 766–781. https://doi.org/10.1016/j.neuroimage.2010.06.013
   PubMed Web of Science ®Google Scholar
• Davatzikos, C., Bhatt, P., Shaw, L. M., Batmanghelich, K. N., & Trojanowski, J. Q. (2011). Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification. Neurobiology of Aging, 32(12), 2322.e19–2322.e27. https://doi.org/10.1016/j.neurobiolaging.2010.05.023
   Web of Science ®Google Scholar
• DeLong, E. R., DeLong, D. M., & Clarke-Pearson, D. L. (1988). Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach. Biometrics, 44(3), 837–845. https://doi.org/10.2307/2531595
   PubMed Web of Science ®Google Scholar
• Deming, Y., Xia, J., Cai, Y., Lord, J., Holmans, P., Bertelsen, S., Holtzman, D., Morris, J. C., Bales, K., Pickering, E. H., Kauwe, J., Goate, A., & Cruchaga, C. (2016). A potential endophenotype for Alzheimer’s disease: Cerebrospinal fluid clusterin. Neurobiology of Aging, 37(208), e1–208.e9. https://doi.org/10.1016/j.neurobiolaging.2015.09.009
   PubMedGoogle Scholar
• Devanand, D. P., Liu, X., Brown, P. J., Huey, E. D., Stern, Y., & Pelton, G. H. (2012). A two-study comparison of clinical and MRI markers of transition from mild cognitive impairment to Alzheimer’s disease. International Journal of Alzheimer’s Disease, 2012, e483469. https://doi.org/10.1155/2012/483469
   PubMedGoogle Scholar
• Eckerström, C., Olsson, E., Bjerke, M., Malmgren, H., Edman, Å., Wallin, A., & Nordlund, A. (2013). A combination of neuropsychological, neuroimaging, and cerebrospinal Fluid markers predicts conversion from mild cognitive iImpairment to dementia. Journal of Alzheimer’s Disease, 36(3), 421–431. https://doi.org/10.3233/JAD-122440
   PubMed Web of Science ®Google Scholar
• Ewers, M., Walsh, C., Trojanowski, J. Q., Shaw, L. M., Petersen, R. C., Jack, C. R., Feldman, H. H., Bokde, A. L. W., Alexander, G. E., Scheltens, P., Vellas, B., Dubois, B., Weiner, M., & Hampel, H., & North American Alzheimer’s Disease Neuroimaging Initiative. (2012). Prediction of conversion from mild cognitive impairment to Alzheimer’s disease dementia based upon biomarkers and neuropsychological test performance. Neurobiology of Aging, 33(7), 1203–1214.e2. https://doi.org/10.1016/j.neurobiolaging.2010.10.019
   PubMed Web of Science ®Google Scholar
• Fjell, A. M., Walhovd, K. B., Fennema-Notestine, C., McEvoy, L. K., Hagler, D. J., Holland, D., Brewer, J. B., & Dale, A. M., for the Alzheimer’s Disease Neuroimaging Initiative. (2010). CSF biomarkers in prediction of cerebral and clinical change in mild cognitive impairment and Alzheimer’s disease. Journal of Neuroscience, 30(6), 2088–2101. https://doi.org/10.1523/JNEUROSCI.3785-09.2010
   PubMed Web of Science ®Google Scholar
• Gibbons, L. E., Carle, A. C., Mackin, R. S., Harvey, D., Mukherjee, S., Insel, P., Curtis, S. M., Mungas, D., & Crane, P. K. (2012). A composite score for executive functioning, validated in Alzheimer’s Disease Neuroimaging Initiative (ADNI) participants with baseline mild cognitive impairment. Brain Imaging and Behavior, 6(4), 517–527. https://doi.org/10.1007/s11682-012-9176-1
   PubMed Web of Science ®Google Scholar
• Giraldo, D. L., Sijbers, J., & Romero, E. (2017). Quantifying cognition and behavior in normal aging, mild cognitive impairment, and Alzheimer’s disease. 13th International Conference on Medical Information Processing and Analysis, 10572, 105720H. https://doi.org/10.1117/12.2287036
   Google Scholar
• Gomar, J. J., Bobes-Bascaran, M. T., Conejero-Goldberg, C., Davies, P., Goldberg, T. E., & Initiative, A. D. N. (2011). Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer’s disease neuroimaging initiative. Archives of General Psychiatry, 68(9), 961–969. https://doi.org/10.1001/archgenpsychiatry.2011.96
   PubMed Web of Science ®Google Scholar
• Gomar, J. J., Conejero-Goldberg, C., Davies, P., & Goldberg, T. E. (2014). Extension and refinement of the predictive value of different classes of markers in ADNI: Four-year follow-up data. Alzheimer’s & Dementia, 10(6), 704–712. https://doi.org/10.1016/j.jalz.2013.11.009
   PubMed Web of Science ®Google Scholar
• Goodglass, H., Kaplan, E., & Weintraub, S. (1983). Boston naming test. Lea & Febiger.
   Google Scholar
• Hampel, H., Teipel, S. J., Padberg, F., Haslinger, A., Riemenschneider, M., Schwarz, M. J., Kötter, H. U., Scheloske, M., Buch, K., Stübner, S., Dukoff, R., Lasser, R., Müller, N., Sunderland, T., Rapoport, S. I., & Möller, H.-J. (1999). Discriminant power of combined cerebrospinal fluid τ protein and of the soluble interleukin-6 receptor complex in the diagnosis of Alzheimer’s disease. Brain Research, 823(1), 104–112. https://doi.org/10.1016/S0006-8993(99)01146-4
   PubMed Web of Science ®Google Scholar
• Hampton, O. L., Mukherjee, S., Properzi, M. J., Schultz, A. P., Crane, P. K., Gibbons, L. E., Hohman, T. J., Maruff, P. T., Lim, Y. Y., Amariglio, R., Papp, K. V., Johnson, K. A., Rentz, D., Sperling, R. A., & Buckley, R. F. (2020). Harmonizing the preclinical Alzheimer cognitive composite for multi-cohort studies. Alzheimer’s & Dementia, 16(S9), e047423. https://doi.org/10.1002/alz.047423
   Google Scholar
• Harrison, J. E., Buxton, P., Husain, M., & Wise, R. (2000). Short test of semantic and phonological fluency: Normal performance, validity and test-retest reliability. British Journal of Clinical Psychology, 39(2), 181–191. https://doi.org/10.1348/014466500163202
   PubMed Web of Science ®Google Scholar
• Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., Herrup, K., Frautschy, S. A., Finsen, B., Brown, G. C., Verkhratsky, A., Yamanaka, K., Koistinaho, J., Latz, E., Halle, A., & Kummer, M. P. (2015). Neuroinflammation in Alzheimer’s disease. The Lancet Neurology, 14(4), 388–405. https://doi.org/10.1016/S1474-4422(15)70016-5
   PubMed Web of Science ®Google Scholar
• Hershberger, S. L. (2005). Factor score estimation. In B. S. Everitt & D. C. Howell (Eds.), Encyclopedia of statistics in behavioral science (pp. 726). John Wiley & Sons, Ltd. https://doi.org/10.1002/0470013192.bsa726
   Google Scholar
• Horn, J. L. (1965). A rationale and test for the number of factors in factor analysis. Psychometrika, 30(2), 179–185. https://doi.org/10.1007/BF02289447
   PubMed Web of Science ®Google Scholar
• Hu, L., & Bentler, P. M. (1999). Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives. Structural Equation Modeling: A Multidisciplinary Journal, 6(1), 1–55. https://doi.org/10.1080/10705519909540118
   Web of Science ®Google Scholar
• Hu, W. T., Watts, K. D., Tailor, P., Nguyen, T. P., Howell, J. C., Lee, R. C., Seyfried, N. T., Gearing, M., Hales, C. M., Levey, A. I., Lah, J. J., & Lee, E. K., for the Alzheimer’s Disease Neuro-Imaging Initiative. (2016). CSF complement 3 and factor H are staging biomarkers in Alzheimer’s disease, Acta Neuropathologica Communications, 4(1), 14. https://doi.org/10.1186/s40478-016-0277-8
   PubMedGoogle Scholar
• Izquierdo, I., & Medina, J. H. (1993). Role of the amygdala, hippocampus and entorhinal cortex in memory consolidation and expression. Brazilian Journal of Medical and Biological Research, 26(6), 573–589.
   PubMed Web of Science ®Google Scholar
• Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., Holtzman, D. M., Jagust, W., Jessen, F., Karlawish, J., Liu, E., Molinuevo, J. L., Montine, T., Phelps, C., Rankin, K. P., Rowe, C. C., Scheltens, P., Siemers, E., Snyder, H. M., … Silverberg, N. (2018). NIA-AA research framework: Toward a biological definition of Alzheimer’s disease. Alzheimer’s & Dementia, 14(4), 535–562. https://doi.org/10.1016/j.jalz.2018.02.018
   PubMed Web of Science ®Google Scholar
• Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010). Hypothetical model of dynamic biomarkers of the Alzheimer’s pathological cascade. The Lancet Neurology, 9(1), 119–128. https://doi.org/10.1016/S1474-4422(09)70299-6
   PubMed Web of Science ®Google Scholar
• Jutten, R. J., Sikkes, S. A. M., Amariglio, R. E., Buckley, R. F., Properzi, M. J., Marshall, G. A., Rentz, D. M., Johnson, K. A., Teunissen, C. E., Van Berckel, B. N. M., Van der Flier, W. M., Scheltens, P., Sperling, R. A., & Papp, K. V., for the Alzheimer Disease Neuroimaging Initiative, & National Alzheimer’s Coordinating Center, the Harvard Aging Brain Study, and the Alzheimer Dementia Cohort. (2021). Identifying sensitive measures of cognitive decline at different clinical stages of Alzheimer’s disease, Journal of the International Neuropsychological Society, 27(5), 426–438. https://doi.org/10.1017/S1355617720000934
   PubMed Web of Science ®Google Scholar
• Kaiser, H. F. (1958). The varimax criterion for analytic rotation in factor analysis. Psychometrika, 23(3), 187–200. https://doi.org/10.1007/BF02289233
   Web of Science ®Google Scholar
• Kaiser, H. F. (1970). A second generation little jiffy. Psychometrika, 35(4), 401–415. https://doi.org/10.1007/BF02291817
   Web of Science ®Google Scholar
• Kaiser, H. F., & Rice, J. (1974). Little jiffy, mark IV. Educational and Psychological Measurement, 34(1), 111–117. https://doi.org/10.1177/001316447403400115
   Web of Science ®Google Scholar
• Kaur, G., & Levy, E. (2012). Cystatin C in Alzheimer’s disease. Frontiers in Molecular Neuroscience, 5, 79. https://doi.org/10.3389/fnmol.2012.00079
   PubMed Web of Science ®Google Scholar
• Khan, W., Aguilar, C., Kiddle, S. J., Doyle, O., Thambisetty, M., Muehlboeck, S., Sattlecker, M., Newhouse, S., Lovestone, S., Dobson, R., Giampietro, V., Westman, E., Simmons, A., & Initiative, A. D. N. (2015). A subset of cerebrospinal fluid proteins from a multi-analyte panel associated with brain atrophy, disease classification and prediction in Alzheimer’s disease. PLOS ONE, 10(8), e0134368. https://doi.org/10.1371/journal.pone.0134368
   PubMed Web of Science ®Google Scholar
• Kuhn, M. (2008). Building predictive models in R using the caret package. Journal of Statistical Software, 28(5), 1–26. https://doi.org/10.18637/jss.v028.i05
   PubMed Web of Science ®Google Scholar
• Kumar, R. G., Diamond, M. L., Boles, J. A., Berger, R. P., Tisherman, S. A., Kochanek, P. M., & Wagner, A. K. (2015). Acute CSF interleukin-6 trajectories after TBI: Associations with neuroinflammation, polytrauma, and outcome. Brain, Behavior, and Immunity, 45, 253–262. https://doi.org/10.1016/j.bbi.2014.12.021
   PubMed Web of Science ®Google Scholar
• Lai, K., & Green, S. B. (2016). The problem with having two watches: Assessment of fit when RMSEA and CFI disagree. Multivariate Behavioral Research, 51(2–3), 220–239. https://doi.org/10.1080/00273171.2015.1134306
   PubMed Web of Science ®Google Scholar
• Landi, S. M., Viswanathan, P., Serene, S., & Freiwald, W. A. (2021). A fast link between face perception and memory in the temporal pole. Science, 373(6554), 581–585. https://doi.org/10.1126/science.abi6671
   PubMed Web of Science ®Google Scholar
• Li, K., Chan, W., Doody, R. S., Quinn, J., & Luo, S. (2017). Prediction of conversion to Alzheimer’s disease with longitudinal measures and time-to-event data. Journal of Alzheimer’s Disease, 58(2), 361–371. https://doi.org/10.3233/JAD-161201
   PubMed Web of Science ®Google Scholar
• Martens, L. H., Zhang, J., Barmada, S. J., Zhou, P., Kamiya, S., Sun, B., Min, S.-W., Gan, L., Finkbeiner, S., Huang, E. J., & Farese, R. V. (2012). Progranulin deficiency promotes neuroinflammation and neuron loss following toxin-induced injury. The Journal of Clinical Investigation, 122(11), 3955–3959. https://doi.org/10.1172/JCI63113
   PubMed Web of Science ®Google Scholar
• Mattsson, N., Insel, P., Nosheny, R., Trojanowski, J. Q., Shaw, L. M., Jack, C. R., Tosun, D., & Weiner, M. (2014). Effects of cerebrospinal fluid proteins on brain atrophy rates in cognitively healthy older adults. Neurobiology of Aging, 35(3), 614–622. https://doi.org/10.1016/j.neurobiolaging.2013.08.027
   PubMed Web of Science ®Google Scholar
• Miners, J. S., Clarke, P., & Love, S. (2017). Clusterin levels are increased in A lzheimer’s disease and influence the regional distribution of Aβ. Brain Pathology, 27(3), 305–313. https://doi.org/10.1111/bpa.12392
   PubMed Web of Science ®Google Scholar
• Mitchell, A. J., & Shiri-Feshki, M. (2009). Rate of progression of mild cognitive impairment to dementia – Meta-analysis of 41 robust inception cohort studies. Acta Psychiatrica Scandinavica, 119(4), 252–265. https://doi.org/10.1111/j.1600-0447.2008.01326.x
   PubMed Web of Science ®Google Scholar
• Moradi, E., Pepe, A., Gaser, C., Huttunen, H., & Tohka, J. (2015). Machine learning framework for early MRI-based Alzheimer’s conversion prediction in MCI subjects. NeuroImage, 104, 398–412. https://doi.org/10.1016/j.neuroimage.2014.10.002
   PubMed Web of Science ®Google Scholar
• Morenas-Rodríguez, E., Cervera-Carles, L., Vilaplana, E., Alcolea, D., Carmona-Iragui, M., Dols-Icardo, O., Ribosa-Nogué, R., Muñoz-Llahuna, L., Sala, I., Belén Sánchez-Saudinós, M., Blesa, R., Clarimón, J., Fortea, J., & Lleó, A. (2016). Progranulin protein levels in cerebrospinal fluid in primary neurodegenerative dementias. Journal of Alzheimer’s Disease, 50(2), 539–546. https://doi.org/10.3233/JAD-150746
   PubMed Web of Science ®Google Scholar
• Morris, J. C. (1993). The Clinical Dementia Rating (CDR): Current version and scoring rules. Neurology, 43(11), 2412–2414. https://doi.org/10.1212/WNL.43.11.2412-a
   PubMed Web of Science ®Google Scholar
• Mueller, S. G., Weiner, M. W., Thal, L. J., Petersen, R. C., Jack, C. R., Jagust, W., Trojanowski, J. Q., Toga, A. W., & Beckett, L. (2005). Ways toward an early diagnosis in Alzheimer’s disease: The Alzheimer’s Disease Neuroimaging Initiative (ADNI). Alzheimer’s & Dementia, 1(1), 55–66. https://doi.org/10.1016/j.jalz.2005.06.003
   PubMedGoogle Scholar
• Park, L. Q., Gross, A. L., McLaren, D. G., Pa, J., Johnson, J. K., Mitchell, M., & Manly, J. J., Alzheimer’s Disease Neuroimaging Initiative. (2012). Confirmatory factor analysis of the ADNI neuropsychological battery. Brain Imaging and Behavior, 6(4), 528–539. https://doi.org/10.1007/s11682-012-9190-3
   PubMed Web of Science ®Google Scholar
• Paterson, R. W., Bartlett, J. W., Blennow, K., Fox, N. C., Shaw, L. M., Trojanowski, J. Q., Zetterberg, H., & Schott, J. M. (2014). Cerebrospinal fluid markers including trefoil factor 3 are associated with neurodegeneration in amyloid-positive individuals. Translational Psychiatry, 4(7), e419–e419. https://doi.org/10.1038/tp.2014.58
   PubMedGoogle Scholar
• Petersen, R. C. (2004). Mild cognitive impairment as a diagnostic entity. Journal of Internal Medicine, 256(3), 183–194. https://doi.org/10.1111/j.1365-2796.2004.01388.x
   PubMed Web of Science ®Google Scholar
• Petersen, R. C. (2011). Mild cognitive impairment. The New England Journal of Medicine, 364(23), 2227–2234. https://doi.org/10.1056/NEJMcp0910237
   PubMed Web of Science ®Google Scholar
• Pfeffer, R. I., Kurosaki, T. T., Harrah, C. H., Jr., Chance, J. M., & Filos, S. (1982). Measurement of functional activities in older adults in the community. Journal of Gerontology, 37(3), 323–329. https://doi.org/10.1093/geronj/37.3.323
   PubMedGoogle Scholar
• Pogue, A. I., Li, Y. Y., Cui, J.-G., Zhao, Y., Kruck, T. P. A., Percy, M. E., Tarr, M. A., & Lukiw, W. J. (2009). Characterization of an NF-κB-regulated, miRNA-146a-mediated down-regulation of complement factor H (CFH) in metal-sulfate-stressed human brain cells. Journal of Inorganic Biochemistry, 103(11), 1591–1595. https://doi.org/10.1016/j.jinorgbio.2009.05.012
   PubMed Web of Science ®Google Scholar
• Portelius, E., Zetterberg, H., Skillbäck, T., Törnqvist, U., Andreasson, U., Trojanowski, J. Q., Weiner, M. W., Shaw, L. M., & Mattsson, N., for the Alzheimer’s Disease Neuroimaging Initiative. (2015). Cerebrospinal fluid neurogranin: Relation to cognition and neurodegeneration in Alzheimer’s disease, Brain, 138(11), 3373–3385. https://doi.org/10.1093/brain/awv267
   PubMedGoogle Scholar
• R Core Team. (2019). R: A language and environment for statistical computing. https://www.R-project.org/
   Google Scholar
• Reitan, R. M., & Wolfson, D. (1985). The Halstead-Reitan neuropsychological test battery: Theory and clinical interpretation (Vol. 4). Reitan Neuropsychology.
   Google Scholar
• Revelle, W. (2016). Psych: Procedures for personality and psychological research (Version 1.6. 12)[Computer software]. Evanston, IL: Northwestern University, 30, 2017.
   Google Scholar
• Rey, A. L. (1964). Presses Universitaires de France. Presses Universitaires de France.
   Google Scholar
• Richard, E., Schmand, B. A., Eikelenboom, P., & Van Gool, W. A. (2013). MRI and cerebrospinal fluid biomarkers for predicting progression to Alzheimer’s disease in patients with mild cognitive impairment: A diagnostic accuracy study. BMJ Open, 3(6), e002541. https://doi.org/10.1136/bmjopen-2012-002541
   PubMed Web of Science ®Google Scholar
• Risacher, S. L., Saykin, A. J., West, J. D., Shen, L., Firpi, H. A., & McDonald, B. C. (2009). Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort. Current Alzheimer Research, 6(4), 347–361. https://doi.org/10.2174/156720509788929273
   PubMed Web of Science ®Google Scholar
• Robin, X., Turck, N., Hainard, A., Tiberti, N., Lisacek, F., Sanchez, J.-C., & Müller, M. (2011). pROC: An open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics, 12(1), 77. https://doi.org/10.1186/1471-2105-12-77
   PubMed Web of Science ®Google Scholar
• Rosen, W. G., Mohs, R. C., & Davis, K. L. (1984). A new rating scale for Alzheimer’s disease. The American Journal of Psychiatry, 141(11), 1356–1364. https://doi.org/10.1176/ajp.141.11.1356
   PubMed Web of Science ®Google Scholar
• Rosseel, Y. (2012). Lavaan: An R package for structural equation modeling and more. Version 0.5–12 (BETA). Journal of Statistical Software, 48(2), 1–36. https://doi.org/10.18637/jss.v048.i02
   Web of Science ®Google Scholar
• Rushton, J. P., Brainerd, C. J., & Pressley, M. (1983). Behavioral development and construct validity: The principle of aggregation. Psychological Bulletin, 94(1), 18–38. https://doi.org/10.1037/0033-2909.94.1.18
   Web of Science ®Google Scholar
• Sando, S. B., Melquist, S., Cannon, A., Hutton, M., Sletvold, O., Saltvedt, I., White, L. R., Lydersen, S., & Aasly, J. (2008). Risk-reducing effect of education in Alzheimer’s disease. International Journal of Geriatric Psychiatry, 23(11), 1156–1162. https://doi.org/10.1002/gps.2043
   PubMed Web of Science ®Google Scholar
• Shaffer, J. L., Petrella, J. R., Sheldon, F. C., Choudhury, K. R., Calhoun, V. D., Coleman, R. E., & Doraiswamy, P. M. (2013). Predicting cognitive decline in subjects at risk for Alzheimer disease by using combined cerebrospinal fluid, MR Imaging, and PET biomarkers. Radiology, 266(2), 583–591. https://doi.org/10.1148/radiol.12120010
   PubMed Web of Science ®Google Scholar
• Shaw, L. M., Vanderstichele, H., Knapik-Czajka, M., Clark, C. M., Aisen, P. S., Petersen, R. C., Blennow, K., Soares, H., Simon, A., Lewczuk, P., Dean, R., Siemers, E., Potter, W., Lee, V. M.-Y., & Trojanowski, J. Q. (2009). Cerebrospinal fluid biomarker signature in Alzheimer’s disease neuroimaging initiative subjects. Annals of Neurology, 65(4), 403–413. https://doi.org/10.1002/ana.21610
   PubMed Web of Science ®Google Scholar
• Shi, F., Liu, B., Zhou, Y., Yu, C., & Jiang, T. (2009). Hippocampal volume and asymmetry in mild cognitive impairment and Alzheimer’s disease: Meta-analyses of MRI studies. Hippocampus, 19(11), 1055–1064. https://doi.org/10.1002/hipo.20573
   PubMed Web of Science ®Google Scholar
• Stern, Y. (2012). Cognitive reserve in ageing and Alzheimer’s disease. Lancet Neurology, 11(11), 1006–1012. https://doi.org/10.1016/S1474-4422(12)70191-6
   PubMed Web of Science ®Google Scholar
• Suárez‐Calvet, M., Kleinberger, G., Araque Caballero, M. Á., Brendel, M., Rominger, A., Alcolea, D., Fortea, J., Lleó, A., Blesa, R., Gispert, J. D., Sánchez‐Valle, R., Antonell, A., Rami, L., Molinuevo, J. L., Brosseron, F., Traschütz, A., Heneka, M. T., Struyfs, H., Engelborghs, S., … Haass, C. (2016). STREM 2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer’s disease and associate with neuronal injury markers. EMBO Molecular Medicine, 8(5), 466–476. https://doi.org/10.15252/emmm.201506123
   PubMed Web of Science ®Google Scholar
• Sun, X., & Xu, W. (2014). Fast implementation of DeLong’s algorithm for comparing the areas under correlated receiver operating characteristic curves. IEEE Signal Processing Letters, 21(11), 1389–1393. https://doi.org/10.1109/LSP.2014.2337313
   Web of Science ®Google Scholar
• Toledo, J. B., Korff, A., Shaw, L. M., Trojanowski, J. Q., & Zhang, J., & the Alzheimer’s Disease Neuroimaging Initiative. (2014). Low levels of cerebrospinal fluid complement 3 and factor H predict faster cognitive decline in mild cognitive impairment. Alzheimer’s Research & Therapy, 6 (3), 36. https://doi.org/10.1186/alzrt266
   PubMed Web of Science ®Google Scholar
• Wechsler, D. (1987). Wechsler memory scale-revised. Psychological Corporation.
   Google Scholar
• Weiner, M. W., Veitch, D. P., Aisen, P. S., Beckett, L. A., Cairns, N. J., Green, R. C., Harvey, D., Jack, C. R., Jagust, W., Morris, J. C., Petersen, R. C., Saykin, A. J., Shaw, L. M., Toga, A. W., & Trojanowski, J. Q. (2017). Recent publications from the Alzheimer’s Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials. Alzheimer’s & Dementia, 13(4), e1–e85. https://doi.org/10.1016/j.jalz.2016.11.007
   PubMed Web of Science ®Google Scholar
• Welge, V., Fiege, O., Lewczuk, P., Mollenhauer, B., Esselmann, H., Klafki, H.-W., Wolf, S., Trenkwalder, C., Otto, M., Kornhuber, J., Wiltfang, J., & Bibl, M. (2009). Combined CSF tau, p-tau181 and amyloid-β 38/40/42 for diagnosing Alzheimer’s disease. Journal of Neural Transmission, 116(2), 203–212. https://doi.org/10.1007/s00702-008-0177-6
   PubMed Web of Science ®Google Scholar
• Whitwell, J. L., Crum, W. R., Watt, H. C., & Fox, N. C. (2001). Normalization of cerebral volumes by use of intracranial volume: Implications for longitudinal quantitative MR imaging. AJNR. American Journal of Neuroradiology, 22(8), 1483–1489.
   PubMed Web of Science ®Google Scholar
• Wilhalme, H., Goukasian, N., De Leon, F., He, A., Hwang, K. S., Woo, E., Elashoff, D., Zhou, Y., Ringman, J. M., & Apostolova, L. G. (2017). A comparison of theoretical and statistically derived indices for predicting cognitive decline. Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, 6, 171–181. https://doi.org/10.1016/j.dadm.2016.10.002
   PubMedGoogle Scholar
• Williams, B., Onsman, A., & Brown, T. (2010). Exploratory factor analysis: A five-step guide for novices. Australasian Journal of Paramedicine, 8(3), 1–13. https://doi.org/10.33151/ajp.8.3.93
   Google Scholar
• Ye, J., Farnum, M., Yang, E., Verbeeck, R., Lobanov, V., Raghavan, N., Novak, G., DiBernardo, A., & Narayan, V. A., for the Alzheimer’s Disease Neuroimaging Initiative. (2012). Sparse learning and stability selection for predicting MCI to AD conversion using baseline ADNI data. BMC Neurology, 12(1), 46. https://doi.org/10.1186/1471-2377-12-46
   PubMedGoogle Scholar
• Yong, A. G., & Pearce, S. (2013). A beginner’s guide to factor analysis: Focusing on exploratory factor analysis. Tutorials in Quantitative Methods for Psychology, 9(2), 79–94. https://doi.org/10.20982/tqmp.09.2.p079
   Google Scholar
• Zhang, D., Shen, D., & Initiative, A. D. N. (2012). Predicting future clinical changes of MCI patients using longitudinal and multimodal biomarkers. PLOS ONE, 7(3), e33182. https://doi.org/10.1371/journal.pone.0033182
   PubMed Web of Science ®Google Scholar